Market-Based Drug Fees: IRS Will Release 2011 Estimates In May, Guidance Says

The IRS guidance proposes a method for calculating the fees and sets out a timetable for the process in 2011, the program's first year. The guidance also describes what corporate entities are liable for the fees and what branded drugs are covered.